Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Eledon Pharmaceuticals (ELDN) Depreciation & Amortization (CF) (2016 - 2017)

Historic Depreciation & Amortization (CF) for Eledon Pharmaceuticals (ELDN) over the last 5 years, with Q3 2017 value amounting to $2000.0.

  • Eledon Pharmaceuticals' Depreciation & Amortization (CF) rose 15000.0% to $2000.0 in Q3 2017 from the same period last year, while for Sep 2017 it was $37000.0, marking a year-over-year decrease of 7643.31%. This contributed to the annual value of $5000.0 for FY2020, which is 4444.44% down from last year.
  • As of Q3 2017, Eledon Pharmaceuticals' Depreciation & Amortization (CF) stood at $2000.0, which was up 15000.0% from $12000.0 recorded in Q2 2017.
  • Over the past 5 years, Eledon Pharmaceuticals' Depreciation & Amortization (CF) peaked at $56000.0 during Q4 2015, and registered a low of -$4000.0 during Q3 2016.
  • Its 5-year average for Depreciation & Amortization (CF) is $16937.5, with a median of $6000.0 in 2014.
  • In the last 5 years, Eledon Pharmaceuticals' Depreciation & Amortization (CF) soared by 102000.0% in 2015 and then tumbled by 11250.0% in 2016.
  • Over the past 5 years, Eledon Pharmaceuticals' Depreciation & Amortization (CF) (Quarter) stood at $3000.0 in 2013, then soared by 66.67% to $5000.0 in 2014, then surged by 1020.0% to $56000.0 in 2015, then crashed by 66.07% to $19000.0 in 2016, then tumbled by 89.47% to $2000.0 in 2017.
  • Its Depreciation & Amortization (CF) was $2000.0 in Q3 2017, compared to $12000.0 in Q2 2017 and $4000.0 in Q1 2017.